Insider · CIK 0001877680
Andrea Ellis
director
Files at BBIO (BridgeBio Pharma, Inc.). First filing Apr 3, 2025, latest Aug 7, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $2.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | BridgeBio Pharma, Inc. | $841k 17,167 shares | -48% | +120% from low0% from high | |
| 13Weak | BridgeBio Pharma, Inc. | $350k 10,000 shares | -45% | +56% from low-7% from high | |
| 33Weak | BridgeBio Pharma, Inc. | $1.0M 30,000 shares | -71% | +48% from low-12% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +17,167 | $16.75 | $288k | 35,756 | Aug 7, 2025 |
| Aug 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -17,167 | $49.00 | $841k | 18,589 | Aug 7, 2025 |
| Aug 5, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -17,167 | $0.00 | $0 | 34,334 | Aug 7, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +6,589 | $0.00 | $0 | 18,589 | Jun 24, 2025 |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +8,425 | $0.00 | $0 | 8,425 | Jun 24, 2025 |
| Apr 14, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $8.45 | $85k | 22,000 | Apr 16, 2025 |
| Apr 14, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $35.00 | $350k | 12,000 | Apr 16, 2025 |
| Apr 14, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 64,921 | Apr 16, 2025 |
| Apr 1, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +30,000 | $8.45 | $254k | 42,000 | Apr 3, 2025 |
| Apr 1, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -30,000 | $34.05 | $1.0M | 12,000 | Apr 3, 2025 |
| Apr 1, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 74,921 | Apr 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.